Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
about
Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinomaEvading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsCompensatory angiogenesis and tumor refractorinessMechanisms of age-related macular degenerationReceptor tyrosine kinase-mediated angiogenesisBroad targeting of angiogenesis for cancer prevention and therapyModification of the tumor microenvironment as a novel target of renal cell carcinoma therapeuticsA PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancerEnhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoproteinAnti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesPrognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab.Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.VEGF-independent angiogenic pathways induced by PDGF-C.Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesisPrognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)Distribution of bone-marrow-derived endothelial and immune cells in a murine colitis-associated colorectal cancer model.Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in miceTumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents.Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Vascularity of nongynecological leiomyosarcoma depends on colony-stimulating factor 1 but not on vascular endothelial growth factor.Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growthINK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury.Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell CarcinomaAnti-VEGF/VEGFR therapy for cancer: reassessing the target.Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.High-Fat, High-Calorie Diet Enhances Mammary Carcinogenesis and Local Inflammation in MMTV-PyMT Mouse Model of Breast CancerLarynx carcinoma regulates tumor-associated macrophages through PLGF signalingHeterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targetsResistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic fluxTargeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy.Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.p120catenin alteration in cancer and its role in tumour invasion.Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients.SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.The role IL-1 in tumor-mediated angiogenesis.HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.
P2860
Q26766240-CDF7B8DE-972A-47C1-8D1E-D8A7983DC226Q26773795-DEA72066-C3F4-484B-A4EF-2870F6DA27FBQ26851916-473B0CAE-8E42-4500-9925-B02685A379E2Q27000182-C74FF52B-511C-489C-8EFC-47BBE229F65CQ27001612-9BBF37D1-5559-406B-BEB4-E7AEC77BEA5BQ27002903-B3BCA5B9-510B-46BC-9BDF-FD89726A9139Q28393614-D5E628A8-E6B0-403A-B1C9-64E94BB3F604Q28485246-C68C7E56-2B0A-4D19-89DD-C1383686BBADQ28586472-F6F2FA90-CB36-44B6-A694-BFC30098E07EQ33688579-FA09EF6C-2C61-4035-B228-0EDD8EE7397FQ33877467-84C51875-8C14-46C1-B9F9-C67B2C7FEDA5Q33939470-BEFB9B6E-F7A7-4EF7-B3B4-83689A5BC4CEQ34149273-35FC994C-6E25-4993-9C68-142C77A8D9F4Q34282386-A5095C60-2B14-4CAE-AA82-D2D049EDBC62Q34447921-83A32829-44DE-4BA9-BA24-D97728CACE51Q34989079-BFE7785C-3685-438B-99EA-7F8B406F1C2AQ35078276-30916FC1-2FB1-47C1-BD56-47AF48289A61Q35109936-043C0C63-B590-48D5-B087-BE78E2D957B0Q35129307-7132CFB4-C48A-4969-86F7-B8B60D4B3BCDQ35131244-F231B5FF-E71C-4B95-AC6F-F00348B83448Q35235604-9419EEA5-D009-4F2E-A020-9E1E23B2D756Q35645125-BD02B2F4-594D-4A8D-B83D-CF40D689C8B2Q35652070-20B6DC90-75AA-4876-B55B-9DE545A16D5DQ35675548-039BFEA9-39F2-4943-BA79-E5924FB69389Q35910772-35847ED8-F33F-4A61-B1C1-DC5BD3801DCAQ36047366-0140DD72-6906-425F-91B5-B3F5A6667C59Q36102802-98DF8388-6D44-40A7-AAA4-C6CF6404C4E6Q36294075-FAC2690C-85C2-44B6-9191-F1F7C893FB4EQ36357152-00763F6A-D513-42D9-AC06-2FE8B7879F27Q36777194-F4F5EAC3-CE10-45F9-8C04-8F6A9EF8A6EAQ36910309-D5EC8DD9-8745-4A5F-978A-AB2B3B3F5FFDQ37148134-E4803682-3B6F-4FC2-BD4F-7C8EA71FDE66Q37174690-0E974D15-4EB4-4376-8423-0786B578FA40Q37204601-19E32D7A-276B-4A5A-9F27-F18217592D87Q37269186-AA30D387-9C14-47F2-8DFB-745FEE4643C8Q37491439-AA8D9155-8B66-404D-9CCC-C60F742A4B98Q37683553-C8341998-FD75-4FFF-8094-92D4B14C09C4Q37689607-B3AC1623-3035-4A64-A666-8F92CE8D651EQ37974937-27A41909-B763-4446-8402-CBBCE1E03614Q37987661-97B422A4-4A79-48B0-B5DB-5B0ADFA7609C
P2860
Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@en
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@nl
type
label
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@en
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@nl
prefLabel
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@en
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@nl
P1476
Role of myeloid cells in vascu ...... ndependent tumor angiogenesis.
@en
P2093
Napoleone Ferrara
P304
P356
10.1097/MOH.0B013E3283386660
P577
2010-05-01T00:00:00Z